Biosimulation in Drug Development 2007
DOI: 10.1002/9783527622672.ch6
|View full text |Cite
|
Sign up to set email alerts
|

The Glucose–Insulin Control System

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

0
10
0

Year Published

2011
2011
2019
2019

Publication Types

Select...
6

Relationship

0
6

Authors

Journals

citations
Cited by 6 publications
(10 citation statements)
references
References 97 publications
0
10
0
Order By: Relevance
“…Obviously, this is still a much simplified, exploratory model; the actual mechanism of glucose-induced insulin secretion in β-cells is complex and involves various molecular-level events [ 1 , 2 , 36 , 37 , 39 , 70 , 96 , 97 ]. The present model gives an adequate quantitative description of the main distinctive features of insulin release, but, at this stage, does not account for interspecies differences and does not incorporate a number of effects known to affect glucose-induced insulin release including, e.g., amplifiers such as glucagon-like peptide-1 (GLP-1) as well as time-dependent effects (i.e., both time-dependent inhibition and potentiation; e.g., the "glucose priming" effect) [ 98 ].…”
Section: Resultsmentioning
confidence: 99%
See 2 more Smart Citations
“…Obviously, this is still a much simplified, exploratory model; the actual mechanism of glucose-induced insulin secretion in β-cells is complex and involves various molecular-level events [ 1 , 2 , 36 , 37 , 39 , 70 , 96 , 97 ]. The present model gives an adequate quantitative description of the main distinctive features of insulin release, but, at this stage, does not account for interspecies differences and does not incorporate a number of effects known to affect glucose-induced insulin release including, e.g., amplifiers such as glucagon-like peptide-1 (GLP-1) as well as time-dependent effects (i.e., both time-dependent inhibition and potentiation; e.g., the "glucose priming" effect) [ 98 ].…”
Section: Resultsmentioning
confidence: 99%
“…In healthy humans, blood glucose levels have to be maintained in a relatively narrow range: typically 4-5 mM and usually within 3.5-7.0 mM (60-125 mg/dL) in fasting subjects [ 1 , 2 ]. This is mainly achieved via the finely-tuned glucose-insulin control system whereby β-cells located in pancreatic islets act as glucose sensors and adjust their insulin output as a function of the blood glucose level.…”
Section: Introductionmentioning
confidence: 99%
See 1 more Smart Citation
“…Assuming that α2 would be within a reasonable range of this value, we constrained α2 to be within [106,5×0.8×VLF] mmol/L/min. The uptake rate of fatty acids, α3, was estimated to be a maximum of 0.6 mmol/min, 21 similarly a wide including this value was confined: [106,2×0.6/VLF] mmol/L/min. The basal source term for plasma TGs, α4 was estimated from the estimate for clearance σ2 (estimated from the fructose DNL experiment 9 ), and reported values for plasma TG concentrations (1.2 mmol/L).…”
Section: Parameter Estimatesmentioning
confidence: 99%
“…Quantitative models describing the dynamics of glucosestimulated insulin secretion are of obvious interest [1] for both type 1 (insulin-dependent or juvenile-onset) [2] and type 2 (non-insulin dependent or adult-onset) diabetes mellitus. Maintenance of glucose levels within the normal range (typically within 3.5 -7.0 mM = 60 -125 mg/ dL in healthy humans) is achieved via the finely-tuned glucose-insulin control system.…”
Section: Introductionmentioning
confidence: 99%